221 related articles for article (PubMed ID: 24227736)
1. Microglial CD33-related Siglec-E inhibits neurotoxicity by preventing the phagocytosis-associated oxidative burst.
Claude J; Linnartz-Gerlach B; Kudin AP; Kunz WS; Neumann H
J Neurosci; 2013 Nov; 33(46):18270-6. PubMed ID: 24227736
[TBL] [Abstract][Full Text] [Related]
2. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of neurotoxicity by microglial human Siglec-11.
Wang Y; Neumann H
J Neurosci; 2010 Mar; 30(9):3482-8. PubMed ID: 20203208
[TBL] [Abstract][Full Text] [Related]
4. Siglec functions of microglia.
Linnartz-Gerlach B; Kopatz J; Neumann H
Glycobiology; 2014 Sep; 24(9):794-9. PubMed ID: 24833613
[TBL] [Abstract][Full Text] [Related]
5. Siglec-h on activated microglia for recognition and engulfment of glioma cells.
Kopatz J; Beutner C; Welle K; Bodea LG; Reinhardt J; Claude J; Linnartz-Gerlach B; Neumann H
Glia; 2013 Jul; 61(7):1122-33. PubMed ID: 23633299
[TBL] [Abstract][Full Text] [Related]
6. CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
Butler CA; Thornton P; Brown GC
J Neurochem; 2021 Jul; 158(2):297-310. PubMed ID: 33720433
[TBL] [Abstract][Full Text] [Related]
7. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
8. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease.
Gonzalez-Gil A; Porell RN; Fernandes SM; Maenpaa E; Li TA; Li T; Wong PC; Aoki K; Tiemeyer M; Yu ZJ; Orsburn BC; Bumpus NN; Matthews RT; Schnaar RL
J Biol Chem; 2022 Jun; 298(6):101960. PubMed ID: 35452678
[TBL] [Abstract][Full Text] [Related]
9. Common determinants of severe Covid-19 infection are explicable by SARS-CoV-2 secreted glycoprotein interaction with the CD33-related Siglecs, Siglec-3 and Siglec-5/14.
Murch SH
Med Hypotheses; 2020 Nov; 144():110168. PubMed ID: 33254494
[TBL] [Abstract][Full Text] [Related]
10. Sialic Acid-Siglec-E Interactions During
Mukherjee K; Khatua B; Mandal C
Front Immunol; 2020; 11():332. PubMed ID: 32184783
[No Abstract] [Full Text] [Related]
11. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
12. CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice.
Brinkman-Van der Linden EC; Angata T; Reynolds SA; Powell LD; Hedrick SM; Varki A
Mol Cell Biol; 2003 Jun; 23(12):4199-206. PubMed ID: 12773563
[TBL] [Abstract][Full Text] [Related]
13. Sialic acid on the neuronal glycocalyx prevents complement C1 binding and complement receptor-3-mediated removal by microglia.
Linnartz B; Kopatz J; Tenner AJ; Neumann H
J Neurosci; 2012 Jan; 32(3):946-52. PubMed ID: 22262892
[TBL] [Abstract][Full Text] [Related]
14. Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33.
Cornish AL; Freeman S; Forbes G; Ni J; Zhang M; Cepeda M; Gentz R; Augustus M; Carter KC; Crocker PR
Blood; 1998 Sep; 92(6):2123-32. PubMed ID: 9731071
[TBL] [Abstract][Full Text] [Related]
15. Control of Innate Immunity by Sialic Acids in the Nervous Tissue.
Liao H; Klaus C; Neumann H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752058
[TBL] [Abstract][Full Text] [Related]
16. Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related Siglecs.
Läubli H; Alisson-Silva F; Stanczak MA; Siddiqui SS; Deng L; Verhagen A; Varki N; Varki A
J Biol Chem; 2014 Nov; 289(48):33481-91. PubMed ID: 25320078
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis.
Salminen A; Kaarniranta K; Kauppinen A
Neurochem Int; 2021 Nov; 150():105186. PubMed ID: 34530055
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
19. Genomic organization of the siglec gene locus on chromosome 19q13.4 and cloning of two new siglec pseudogenes.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Gene; 2002 Mar; 286(2):259-70. PubMed ID: 11943481
[TBL] [Abstract][Full Text] [Related]
20. Gene conversions are frequent but not under positive selection in the Siglec gene families of primates.
Zid M; Drouin G
Genome; 2014 Jun; 57(6):317-25. PubMed ID: 25166301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]